Applications from all three bidders interested in a strategic partnership at Serbia’s pharmaceuticals company Galenika “arrived in a timely manner.”
They were also submitted “pursuant to requirements,” a commission in charge of the procedure for establishing the partnership announced after the applications were opened on Friday.
Only envelopes containing bidder information were opened at a session held by the commission and the documentation provided will be evaluated and analyzed within the shortest period of time possible, the Ministry of Economy said in a statement.
At the next session, scheduled for August 2, the commission will present a report on the bidder documentation received.
The financial bids will be opened once all documentation has been deemed to have been submitted pursuant to the rules of procedure for establishing a strategic partnership, the statement said.
The bids were submitted by Cadila Pharmaceuticals Limited of India, EMS SA of Brazil and a consortium of UK-based Frontier Pharma Limited and Russia’s LLC NPA Petrovax Pharm.
Source; B92
